TITLE

Ultra-Low-Dose Chest CT in Patients with Neutropenic Fever and Hematologic Malignancy: Image Quality and Its Diagnostic Performance

AUTHOR(S)
Hae Jin Kim; So Young Park; Ho Yun Lee; Kyung Soo Lee; Kyung Eun Shin; Jung Won Moon
PUB. DATE
October 2014
SOURCE
Cancer Research & Treatment;2014, Vol. 46 Issue 4, p393
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose The aim of this study was to evaluate the image quality of ultra-low-dose computed tomography (ULDCT) and its diagnostic performance in making a specific diagnosis of pneumonia in febrile neutropenic patients with hematological malignancy. Materials and Methods ULDCT was performed prospectively in 207 febrile neutropenic patients with hematological malignancy. Three observers independently recorded the presence of lung parenchymal abnormality, and also indicated the cause of the lung parenchymal abnormality between infectious and noninfectious causes. If infectious pneumonia was considered the cause of lung abnormalities, they noted the two most appropriate diagnoses among four infectious conditions, including fungal, bacterial, viral, and Pneumocystis pneumonia. Sensitivity for correct diagnoses and receiver operating characteristic (ROC) curve analysis for evaluation of diagnostic accuracy were calculated. Interobserver agreements were determined using intraclass correlation coefficient. Results Of 207 patients, 139 (67%) had pneumonia, 12 had noninfectious lung disease, and 56 had no remarkable chest computed tomography (CT) (20 with extrathoracic fever focus and 36 with no specific disease). Mean radiation expose dose of ULDCT was 0.60±0.15 mSv. Each observer regarded low-dose CT scans as unacceptable in only four (1.9%), one (0.5%), and three (1.5%) cases of ULDCTs. Sensitivity and area under the ROC curve in making a specific pneumonia diagnosis were 63.0%, 0.65 for reader 1; 63.0%, 0.61 for reader 2; and 65.0%, 0.62 for reader 3; respectively. Conclusion ULDCT, with a sub-mSv radiation dose and acceptable image quality, provides ready and reasonably acceptable diagnostic information for pulmonary infection in febrile neutropenic patients with hematologic malignancy.
ACCESSION #
98855010

 

Related Articles

  • Febrile neutropenia: significance of elaborated screening for respiratory viruses, and the comparison of different sampling methods, in neutropenic patients with hematological malignancies. Jansen, Rogier R.; Biemond, Bart J.; Schinkel, Janke; Koekkoek, Sylvie M.; Molenkamp, Richard; de Jong, Menno D.; Visser, Caroline E. // Virology Journal;2013, Vol. 10 Issue 1, p1 

    Background: During febrile neutropenia in only 30 to 60 percent an infectious agent is identified. This diagnostic gap could hypothetically be reduced with the broad implementation of molecular detection techniques like PCR, which has revolutionized the detection of infectious diseases during...

  • Clinical Experience in Invasive Fungal Infections. Pacheco, Patrícia; Ventura, Ana; Branco, Teresa; Gonçalves, Lucília; Carvalho, Célia // Clinical Drug Investigation;Feb2013 Supplement, Vol. 33, p23 

    Lung infections caused by invasive filamentous fungi are very rare conditions in AIDS, but must be considered in patients with profound immune suppression especially in the presence of additional risk factors, such as hematologic malignancies, corticosteroid therapy, neutropenia, and...

  • Bacterial Landscape of Bloodstream Infections in Neutropenic Patients via High Throughput Sequencing. Gyarmati, Peter; Kjellander, Christian; Aust, Carl; Kalin, Mats; Öhrmalm, Lars; Giske, Christian G. // PLoS ONE;8/13/2015, Vol. 10 Issue 8, p1 

    Background: Bloodstream infection (BSI) is a common and potentially life-threatening complication in patients with hematological malignancies and therapy-induced neutropenia. Administration of broad spectrum antibiotics has substantially decreased the mortality rate in febrile neutropenia, but...

  • 64 multidetector CT findings of influenza A (H1N1) virus in patients with hematologic malignancies. El-Badrawy, Adel; Zeidan, Amany; Ebrahim, Mohamed A. // Acta Radiologica;Jul2012, Vol. 53 Issue 6, p662 

    Background: The pandemic of swine-origin H1N1 influenza that began in early 2009 has provided evidence that radiology can assist in the early diagnosis of severe cases. Immunocompromised patients are at increased risk for morbidity and mortality. MDCT is superior to radiography in showing the...

  • What does the term 'survivor' mean to individuals diagnosed with a haematological malignancy? Findings from Australia. McGrath, Pam; Holewa, Hamish // Supportive Care in Cancer;Dec2012, Vol. 20 Issue 12, p3287 

    Purpose: The use of the word 'survivor' is now widely accepted in academic and clinical oncology culture. However, despite such prevalence, there is limited research exploring the meaning of the term survivor for the very individuals to which the term is applied. The article provides insights on...

  • Mucorales-Specific T Cells in Patients with Hematologic Malignancies. Potenza, Leonardo; Vallerini, Daniela; Barozzi, Patrizia; Riva, Giovanni; Gilioli, Andrea; Forghieri, Fabio; Candoni, Anna; Cesaro, Simone; Quadrelli, Chiara; Maertens, Johan; Rossi, Giulio; Morselli, Monica; Codeluppi, Mauro; Mussini, Cristina; Colaci, Elisabetta; Messerotti, Andrea; Paolini, Ambra; Maccaferri, Monica; Fantuzzi, Valeria; Del Giovane, Cinzia // PLoS ONE;2/12/2016, Vol. 11 Issue 2, p1 

    Background: Invasive mucormycosis (IM) is an emerging life-threatening fungal infection. It is difficult to obtain a definite diagnosis and to initiate timely intervention. Mucorales-specific T cells occur during the course of IM and are involved in the clearance of the infection. We have...

  • Combining standard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropenia. Paholcsek, Melinda; Fidler, Gabor; Konya, Jozsef; Rejto, Laszlo; Mehes, Gabor; Bukta, Evelin; Loeffler, Juergen; Biro, Sandor // BMC Infectious Diseases;Jul2015, Vol. 15 Issue 1, p1 

    Background: We assessed the diagnostic value of standard clinical methods and combined biomarker testing (galactomannan assay and polymerase chain reaction screening) in a prospective case-control study to detect invasive pulmonary aspergillosis in patients with hematological malignancies and...

  • Diagnostic value of bronchoscopy in patients with hematologic malignancy and pulmonary infiltrates. Kim, Sei; Rhee, Chin; Kang, Hye; Lee, Hye; Kang, Ji; Kim, Seung; Kim, Seok; Lee, Sook; Kim, Young; Lee, Jong // Annals of Hematology;Jan2015, Vol. 94 Issue 1, p153 

    Pulmonary infections are a major cause of morbidity and mortality in patients with hematologic malignancy. Bronchoscopy is at present still the traditional first investigation in immunosuppressed patients that have developed pulmonary infiltrates. There is limited data available on the validity...

  • Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis. Chong, Yong; Shimoda, Shinji; Yakushiji, Hiroko; Ito, Yoshikiyo; Aoki, Takatoshi; Miyamoto, Toshihiro; Kamimura, Tomohiko; Shimono, Nobuyuki; Akashi, Koichi // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Background: Fluoroquinolone prophylaxis in patients with neutropenia and hematological malignancies is said to be effective on febrile netropenia (FN)-related infection and mortality; however, the emergence of antibiotic resistance has become a concern. Ciprofloxacin and levofloxacin prophylaxis...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics